In premarket trading, Albemarle Corp jumped nearly 9 per cent, while Chile's Sociedad Quimica y Minera rose 6.5 per cent and Lithium Americas gained nearly 9 per cent
The biopharma company's revenue from operations for the quarter ended June 30, 2025, surged 15 per cent year-on-year (Y-o-Y) to ₹3,942 crore, as compared to ₹3,433 crore reported in Q1FY25.
Broader markets witnessed a steeper decline. The Nifty Midcap 100 was trading 0.86 per cent lower, quoting 56,449 levels. Nifty Smallcap, meanwhile, was trading at 17,594, down by 0.56 per cent.
The company reported a 40 per cent rise in its profit after tax (PAT) figure to ₹589.27 crore during the quarter ended June 30, 2025, as against ₹419.8 crore reported in Q1FY25
The integrated steel company reported a 1 per cent year-on-year (Y-o-Y) decline to ₹1,323 crore during the quarter ended June 30, 2025
The pharma company's profit after tax (PAT) for the quarter ended June 30, 2025, stood at ₹215 crore, up 50 per cent from ₹143 crore reported in the corresponding quarter of the previous fiscal year.
The public issue was valued at ₹4,011.60 crore and consisted entirely of an offer for sale with shareholders offloading up to 50.1 million equity shares.
The buying interest on the counter came after the company announced that its joint venture (JV) with RBL Bank emerged as the lowest (L1) bidder for contract worth ₹1,503.63 crore
The company's earnings before interest, taxes, depreciation and amortization (Ebitda) stood at ₹414 crore during the quarter, down from ₹542 crore reported in the year-ago period
MCX reported a profit after tax (PAT) of ₹203.19 crore during the quarter ended June 30, 2025, up 83 per cent from ₹110.92 crore reported in the year ago period
The company's overall income for the quarter ended June 30, 2025, stood at ₹908 crore, as compared to ₹369 crore reported in the corresponding period of the previous fiscal year.
Majority of stocks from the Sensex pack were trading in red with Sun Pharma, Tata Steel, Tata Motors, Infosys and Tech Mahindra among the top laggards.
Stocks to buy: Motilal Oswal's research desk recommends HDFC Bank, Delhivery, Tata Consumer Products and others; check full list here
F&O stocks: For Apollo Hospitals, the short-term trend is positive as it is placed above its 5, 11 and 20-day EMA.
IIFL Finance dipped 5% post after the company reported a 19% decline in Q1 net profit.
The buying interest on the counter came after the company announced its results for the first quarter of financial year 2025-2026 (Q1FY26).
The company's profit after tax (PAT) for the quarter ended June 30, 2025, stood at ₹74.6 crore, as compared to ₹50.8 crore recorded in Q1FY25.
Grasim Industries has negated lower highs-lower lows after four weeks and has pulled back higher from its 100 DEMA support.
The NBFC's net interest margin (NIM) declined to 16.43 per cent in Q1FY26, as against 16.84 per cent reported in the previous quarter (Q4FY25)
At 12:10 PM, NTPC shares were trading at ₹340.55, up by 1.78 per cent on the National Stock Exchange.